首页 | 本学科首页   官方微博 | 高级检索  
     

深圳市部分药品行业从业人员对药品不良反应损害补偿的认知、态度与行为的调查分析
引用本文:邢惟青,左丽,吴斌,王茜,吴建茹. 深圳市部分药品行业从业人员对药品不良反应损害补偿的认知、态度与行为的调查分析[J]. 中国药房, 2020, 0(13): 1650-1653
作者姓名:邢惟青  左丽  吴斌  王茜  吴建茹
作者单位:深圳市药物警戒和风险管理研究院
基金项目:广东省食品药品监督管理局科技创新项目(No.2018TDB27);深圳市科技计划项目(No.JCYJ20170818104824165)。
摘    要:
目的:调查深圳市部分药品行业从业人员对药品不良反应(ADR)损害补偿的认知、态度与行为,为建立该市ADR损害补偿制度提供依据。方法:以2018年深圳市召开的相关会议中的药品上市许可持有人(MAH)、二级及以上医疗机构与药品监管部门工作人员为调查对象,采用"问卷星"小程序现场匿名调查的方式,收集并分析上述人员对ADR损害补偿的认知、态度(包括对ADR损害赔偿的态度和对ADR损害补偿制度的态度)与行为等,并提出相关建议。结果与结论:共收集填写完整调查问卷172份(均为有效问卷)。认知方面,调查对象对于ADR的认知普遍较高(ADR概念正确认知占比为82.0%)。对ADR损害赔偿态度方面,100名(58.1%)调查对象认为用药后发生了ADR应该获得赔偿,147名(85.5%)调查对象认为应对严重(含死亡)的ADR进行补偿;对ADR损害补偿制度态度方面,对于ADR损害补偿经费,选择应该由MAH承担的有131例次(76.2%);对于推行ADR损害补偿存在的困难,多数被调查者认为ADR跟药物相关性的评价困难导致推行ADR损害补偿存在困难(143例次,83.1%);大部分调查对象认为推行ADR补偿制度...

关 键 词:深圳市  药品行业从业人员  药品不良反应  损害补偿  认知  态度  行为

Investigation and Analysis of Cognition,Attitude and Behavior of Part of Drug Practitioners in Shenzhenon Compensation of Adverse Drug Reaction Injury
XING Weiqing,ZUO Li,WU Bin,WANG Qian,WU Jianru. Investigation and Analysis of Cognition,Attitude and Behavior of Part of Drug Practitioners in Shenzhenon Compensation of Adverse Drug Reaction Injury[J]. China Pharmacy, 2020, 0(13): 1650-1653
Authors:XING Weiqing  ZUO Li  WU Bin  WANG Qian  WU Jianru
Affiliation:(Shenzhen Institute of Pharmacovigilance and Risk Management,Guangdong Shenzhen 518000,China)
Abstract:
OBJECTIVE:To investigate the cognition,attitude and behavior of part of drug practitioners in Shenzhen on compensation of adverse drug reaction(ADR)injury,and to provide relevant reference for the establishment of ADR injury compensation system.METHODS:Taking marketing authorization holder(MAH),staff of medical institutions at the second level or above and drug regulatory authorities in the relevant meeting held in Shenzhen in 2018 as objects,on-the-spot anonymous investigation of“questionnaire star”was used to collect and analyze the cognition,attitude(including attitude towards ADR compensation and ADR compensation system)and behavior of the above-mentioned personnel to ADR compensation.The relevant suggestion was put forward.RESULTS&CONCLUSIONS:A total of 172 questionnaires were collected(all being valid).In term of cognition,the respondents generally had high awareness of ADR(response rate of ADR concept was 82.0%).In term of attitude to ADR injury compensation,100 respondents(58.1%)believed that ADR after medication should be compensated,and 147 respondents(85.5%)believed that compensation should be made for serious and fatal adverse reactions.In term of attitude to ADR injury compensation system,respondents thought that ADR damage compensation funds be undertaken by MAH for 131 case times(76.2%).As for the difficulties in the implementation of ADR compensation,it was considered that the evaluation of the correlation between adverse reactions and drugs led to the difficulties in the implementation of ADR compensation(143 case times,83.1%);most respondents thought that the first thing to do in the implementation of ADR compensation system was to implement laws and regulations(145 case times,84.3%).In term of behavior,104 respondents(60.5%)had processed costs due to ADR,most of whom chose self-resolved(85 cases,81.7%);112 respondents(65.1%)chose to inform medical personnels or pharmacies directly.It is suggested that the relevant departments in Shenzhen should explore and establish ADR injury compensation mechanism in Shenzhen by establishing a public oriented platform and mechanism for ADR science popularization(setting up relevant departments,supervising the public propaganda of news media,expanding the public propaganda to the community),exploring and establishing ADR injury compensation mechanism(setting up a special legislativepilot of ADR injury regulations,setting up ADR injury appraisal committee),and increasing the investment in ADR testing(fullyusing of“Internet+”Big Data,allocating special funds).
Keywords:Shenzhen  Drug practitioners  ADR  Injury compensation  Cognition  Attitude  Behavior
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号